The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $0.47 in the prior trading day, FSD Pharma Inc (NASDAQ: HUGE) closed at $0.49, up 4.78%. In other words, the price has increased by $4.78 from its previous closing price. On the day, 0.69 million shares were traded. HUGE stock price reached its highest trading level at $0.53 during the session, while it also had its lowest trading level at $0.45.
Ratios:
Our goal is to gain a better understanding of HUGE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.43 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUGE now has a Market Capitalization of 20010076 and an Enterprise Value of 16115529.
Stock Price History:
The Beta on a monthly basis for HUGE is 0.66, which has changed by -0.6782895 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, HUGE has reached a high of $1.68, while it has fallen to a 52-week low of $0.42. The 50-Day Moving Average of the stock is -34.71%, while the 200-Day Moving Average is calculated to be -52.34%.
Shares Statistics:
The stock has traded on average 147.92K shares per day over the past 3-months and 180090 shares per day over the last 10 days, according to various share statistics. A total of 39.38M shares are outstanding, with a floating share count of 34.20M. Insiders hold about 15.42% of the company’s shares, while institutions hold 1.21% stake in the company. Shares short for HUGE as of 1711584000 were 333369 with a Short Ratio of 2.25, compared to 1709164800 on 364175. Therefore, it implies a Short% of Shares Outstanding of 333369 and a Short% of Float of 0.97.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $8.68M in the next fiscal year. The high estimate is $8.68M and the low estimate is $8.68M. The average revenue growth estimate for next year is up 205.60% from the average revenue estimate for this year.
